Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220. (Q34147433)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220. |
scientific article |
Statements
1 reference
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220. (English)
1 reference
E T Overton
1 reference
M Kang
1 reference
M G Peters
1 reference
T Umbleja
1 reference
B L Alston-Smith
1 reference
B Bastow
1 reference
D Demarco-Shaw
1 reference
M J Koziel
1 reference
L Mong-Kryspin
1 reference
H L Sprenger
1 reference
J Y Yu
1 reference
J A Aberg
1 reference
23 June 2010
1 reference
1 reference
28
1 reference
34
1 reference
5597-5604
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference